SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-16-006614
Filing Date
2016-10-04
Accepted
2016-10-04 16:58:44
Documents
11
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 20-F zk1619058.htm 20-F 3220070
2 EXHIBIT 4.19 exhibit_4-19.htm EX-4.19 235364
3 EXHIBIT 4.20 exhibit_4-20.htm EX-4.20 233266
4 EXHIBIT 8.1 exhibit_8-1.htm EX-8.1 2250
5 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 10442
6 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 10508
7 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 4814
8 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 4822
9 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 2612
10 image0.jpg GRAPHIC 11580
11 image00001.jpg GRAPHIC 3488
  Complete submission text file 0001178913-16-006614.txt   3746126
Mailing Address LEVEL 2 369 ROYAL PARADE PARKVILLE, VICTORIA C3 3052
Business Address LEVEL 2 369 ROYAL PARADE PARKVILLE, VICTORIA C3 3052 61-3-9349-4906
PRANA BIOTECHNOLOGY LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-49843 | Film No.: 161919802
SIC: 2834 Pharmaceutical Preparations